Cordant Health Solutions™ partners with clinician practices and other stakeholders to provide a pharmacy solution that specializes in safely and securely dispensing medications for the treatment of behavioral health conditions, including medication-assisted treatment (MAT) for opioid and substance use disorders.
Integrating Cordant’s suite of drug testing, pharmacy and data analytics solutions can help promote patient safety, engagement and adherence to treatment protocols and increases visibility into patient behavior for early intervention.
Cordant’s stigma-free buprenorphine distribution program improves access to the medications used to treat opioid use disorder.
Analysis of 96 integrated patients; Jan. 2017–Sept. 2018
Analysis of 496 pharmacy patients; Jan 2017 – Sept 2018 | Hser, Y. et al. (2013), Treatment retention among patients randomized to buprenorphine/ naloxone compared to methadone in multi-site trial. Addiction; 109(1): 79-87